Cervix cancer with various immunotherapies and different checkpoint inhibitors
Description
Cervix cancer produced by the human papilloma virus. Here it shows how the human papilloma virus induced the cervix cancer and for the treatment various immunotherapies are demonstrated such as combined immunotherapy , adoptive immunotherapy, how different immune checkpoint inhibitors suppresses the cervix tumour as well as CD8 + T cells and antigen affects the tumour. Here is the demonstration of PDL-1 and CTLA-4 function during the immunotherapy treatment.
Acknowledgements
References
Dennis, M., Burak, Z., Joan, T. R., Harold, J., & Santin, A. D. (2021). Immunotherapy in Cervical Cancer. Current Oncology Reports, 23(6).
Ferrall, L., Lin, K. Y., Roden, R. B., Hung, C. F., & Wu, T. C. (2021). Cervical cancer immunotherapy: facts and hopes. Clinical Cancer Research, 27(18), 4953-4973.
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
.gif)
